Despite its worldwide ban, the warfare agent sulfur mustard (SM) still represents a realistic threat, due to potential release in terroristic attacks and asymmetric conflicts. Therefore, the rigorous and quantitative detection of SM exposure is crucial for diagnosis, health risk assessment, and surveillance of international law. Alkylation adducts of nucleic acids can serve as valuable toxicologically relevant 'biomarkers of SM exposure'. Here, we developed a robust and versatile bioanalytical platform based on isotope dilution UPLC-MS/MS to quantify major SM-induced DNA and RNA adducts, as well as adducts induced by the monofunctional mustard 2-chloroethyl ethyl sulfide. We synthesized 15 N/ 13 C-labeled standards, which allowed absolute quantitation with full chemical specificity and subfemtomole sensitivities. DNA and RNA mono-alkylation adducts and crosslinks were carefully analyzed in a dose-and time-dependent manner in various matrices, including human cancer and primary cells, derived of the main SM-target tissues. Nucleic acid adducts were detected up to 6 days post-exposure, indicating long persistence, which highlights their toxicological relevance and proves their suitability as forensic and medical biomarkers. Finally, we investigated ex vivo-treated rat skin biopsies and human blood samples, which set the basis for the implementation into the method portfolio of Organization for the Prohibition of Chemical Weapons-designated laboratories to analyze authentic samples from SM-exposed victims.
Introduction
Sulfur mustard (SM) is one of the first chemical warfare agents used in World War I (WWI) (Mangerich and Esser 2014; Steinritz and Thiermann 2016) . The use of SM as a warfare agent was first proscribed by the Geneva protocol in 1925 and finally banned by the Chemical Weapons Convention in 1992 (Hoenig 2002; United Nations Treaty Collection 1992) . Despite this, SM was broadly used in the Iran-Iraq War (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) and even recently in asymmetric conflicts, such as in Syria and Iraq (Dons 2013; OPCW 2017; Thiermann et al. 2013 ). Due to ease of chemical synthesis as well as potentially undestroyed residual stockpiles in conflict areas, it may also be accessible for terroristic groups (BalaliMood and Hefazi 2005; Wang 2010 ). Therefore, SM still represents a realistic threat, both for civilians and soldiers, which calls for reliable, specific, and sensitive exposure assessment.
Sulfur mustard is a vesicant, inducing severe skin pathologies within 2-24 h post-exposure, which are characterized by erythema and blisters formed by cell death of keratinocytes and subsequent dermal-epidermal separation. In the long term, this can result in ulceration and pigmentation disorders (Kehe et al. 2009; Steinritz and Thiermann 2016) . In addition, the eyes and the respiratory tract are other major targets of SM-induced toxicity (Kehe et al. 2009 ). Long-term effects include impaired wound healing, chronic suppression of the immune system, and carcinogenesis, such as the development of lung cancers (Balali-Mood and Hefazi 2005; Doi et al. 2011; Hosseini-khalili et al. 2009; Mukaida et al. 2017) . Moreover, early on, it was recognized that SM suppresses hematopoiesis and causes bone marrow depletion and leukopenia (Balali-Mood and Hefazi 2005; Krumbhaar 1919; Pappenheimer and Vance 1920; Vedder 1925) . This observation led to initial attempts to use SM as an anti-leukemic drug (Adair and Bagg 1931) and later on to the development of nitrogen mustard-based chemotherapeutics, many of which are still in clinical use for the treatment of several types of cancers (Cheung-Ong et al. 2013; Einhorn 1985) .
Mechanistically, SM represents a highly reactive compound, which alkylates cellular macromolecules like DNA, RNA, and proteins. It reacts via an episulfonium ion with nucleophilic sites, e.g., nitrogen and oxygen atoms of DNA nucleobases as well as the C8 position of purines. Major molecular targets include guanine at the N7 position, leading to N7-(2-hydroxyethylthioethyl) guanine (N7-HETE-Gua, ~ 61% of analyzed adducts), but also the N3 position of adenine, leading to N3-(2-hydroxyethylthioethyl) adenine (N3-HETE-Ade, ~ 16% of analyzed adducts) (Kehe et al. 2009; Ludlum et al. 1994) . The highly mutagenic adduct O 6 -(2-hydroxyethylthioethyl) guanine (O 6 -HETE-Gua) was identified only at very low frequencies of ~ 0.1% ( Fig. 1) (Ludlum et al. 1986 ). As a bi-functional agent, SM also induces DNA crosslinks, such as bis [2-(guanine-7-yl) ethyl] sulfide (Bis-Gua, ~ 17% of analyzed adducts) (Lawley and Brookes 1967) . The mono-alkylating analog 2-chloroethyl ethyl sulfide (CEES, also known as half-mustard) is commonly used as a less-toxic and non-restricted surrogate for SMrelated research purposes. Reaction of nucleic acids with CEES leads to N7-(ethylthioethyl) guanine (N7-ETE-Gua) and N7-(ethylthioethyl) adenine (N3-ETE-Ade) adducts. DNA damage is considered the prime causative factor for SM-related toxicities (Batal et al. 2013a; Shakarjian et al. 2010; Yue et al. 2014) , by inducing genomic instability, mutations, and cell death, which can result in a sustained inflammation and tumorigenic transformation (Kehe et al. 2008b (Kehe et al. , 2009 Mangerich et al. 2016; Steinritz and Thiermann 2016) . In particular, DNA crosslinks are highly cytotoxic, leading to replication stress and secondary damage, such as DNA double strand breaks (Deans and West 2011) .
Immunochemical methods can be used for the rapid and preliminary assessment of SM exposure (Kehe et al. 2008a; Steinritz and Thiermann 2016) . However, such methods are limited in their chemical specificity and sensitivity, and exhibit a low linear range of quantitation. Therefore, immunochemical methods are only considered as indicative evidence of SM exposure (Battista et al. 1996) . To verify the use of a chemical weapon, the Organization for the Prohibition of Chemical Weapons (OPCW) demands at least two different-ideally independent-bioanalytical methods, preferably based on spectrometric verification by mass spectrometry, and infrared-or nuclear magnetic resonance spectroscopy (Tabassi 2015) . In particular, mass spectrometry provides full chemical specificity, high analytical sensitivity, accuracy, and reproducibility, and is, therefore, considered highly suited for exposure verification in court procedures (Remane et al. 2016) . One approach to verify SM exposure by mass spectrometry represents the measurement of SM-protein adducts in blood, e.g., serum albumin and hemoglobin, which enables relatively long time windows
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O 6 -HETE-Gua Bis-Gua N3-HETE-Ade + 105.0, whereas BisGua results in a fragment of [M] + 210.0 of detection of up to 41 day post-exposure (Gandor et al. 2015; John et al. 2016a; Liu et al. 2015; Newmark et al. 2007; Noort et al. 2008; . Therefore, blood-derived SM-protein adducts represent well-suited forensic 'biomarkers of exposure'. In comparison to protein adducts, SM-DNA adducts are considered mechanism-based and more toxicologically relevant biomarkers, which would allow health risk assessment, particularly in terms of assessment of cancer risks (Zubel et al. 2018 ). For absolute quantitation of DNA adducts, isotope-labeled chemical standards can be used, which account for technical variability during sample preparation and mass spectrometric analysis. Such targeted isotope dilution LC-MS/MS (ID-LC-MS/MS) approaches are currently considered the gold standard for the analysis of a broad range of DNA adducts (Tretyakova et al. 2012; Zubel et al. 2018) . Thus, mass spectrometric monitoring and quantitation of SM-induced nucleic acid adducts can help to identify and verify exposed individuals, as a method complementing the analysis of SM-protein adduct. In addition, analysis of SM-DNA adducts can set a basis to investigate SM-induced toxicology on a molecular level, thereby contributing to an improved understanding of the mode of action of SM-induced toxicity and the development of effective countermeasures.
Up to now, a limited number of LC-MS/MS approaches to quantify SM-induced DNA adducts have been reported [reviewed in (Zubel et al. 2018) ]. Thus, Batal et al. analyzed the three most abundant DNA adducts N7-HETE-Gua, N3-HETE-Ade, and Bis-Gua in SM-treated DNA and human leukemic monocytes with limits of detection in the femtomole range (Batal et al. 2013a ). The method is based on the use of external calibration curves, by which it lacks the addition of an internal standard for absolute quantitation. Follow-up studies focused on the systemic analysis of adduct distributions in internal organs (Batal et al. 2013b (Batal et al. , 2014 . Yue et al. quantitatively assessed the four SM adducts N7-HETE-Gua, N3-HETE-Ade, Bis-Gua, and O 6 -HETE-Gua . They used deuterated standards for internal calibration, reaching detection limits in the subfemtomole range. Follow-up studies focused on urinary excretion of metabolites and adduct distributions in different rodent organs (Yue et al. 2015; Zhang et al. 2014) . In addition, these authors analyzed adduct levels in adipocyte cell lines and adipose tissue, suggesting a depot effect of SM in lipidrich environments (Wang et al. 2015 ).
In the current study, we have developed and applied a largely improved and extended mass spectrometric platform based on ID-UPLC-MS/MS for the sensitive, specific, and absolute quantitation of the most relevant mustard-induced DNA and RNA adducts. To this end, we developed methods for sample preparation, chromatographic and mass spectrometric analyses, and the synthesis and purification of 13 C, 15 N-labeled chemical standards. We applied and validated these methods for adduct quantitation in a broad range of biological matrices, including human primary cells and whole blood, as well as rat skin. We carefully examined DNA/RNA adduct levels in a concentration and timedependent manner, proving the suitability of the methods for biomarker analyses and mechanistic studies. Currently, the bioanalytical platform is implemented into the method portfolio of the Institute of Pharmacology and Toxicology of the Bundeswehr, Munich, Germany, which is an OPCWdesignated laboratory, and has already led to the first applications in follow-up research projects (Tsoutsoulopoulos et al., manuscript in preparation). 
Materials and methods

Chemicals
Cell culture
HaCaT and A549 cells were cultured in DMEM (Thermo Scientific) supplemented with 10% fetal calf serum (Biochrome) and 1% penicillin-streptomycin (Thermo Scientific) at 37 °C in a humidified incubator with 5% CO 2 . Cells were washed with PBS (Biochrome) and detached with trypsin-EDTA (0.05%, Thermo Scientific). Primary normal human epidermal keratinocytes (NHEKs) (adult, pooled, PromoCell) were cultured in Keratinocyte Growth Medium 2 (ready-to-use, PromoCell) at 37 °C in a humidified incubator with 5% CO 2 . Cells were detached using Accutase solution (PromoCell) after washing with HEPES BSS (PromoCell).
SM and CEES treatment of DNA
One milligram of calf thymus (CT) DNA (Sigma-Aldrich) or baker's yeast RNA (Sigma-Aldrich) were dissolved overnight at 4 °C in 1 ml Na 2 HPO 4 buffer (50 mM, pH 7). Solutions of SM in ethanol (EtOH) or CEES in EtOH/HCl (95%, v/v/0.5%, v/v) were prepared freshly (200 × of final concentration). Final dilutions were performed in pre-warmed PBS. Solvent controls were treated with 0.5% (v/v) solvent in PBS. Incubation was performed for 1 h at room temperature 1 3 (RT). DNA was precipitated with 350 µl isopropanol, centrifuged at 5000 × g for 15 min at 4 °C, and washed with 250 µl cold EtOH (70%, v/v). Pellets were dried at 37 °C and resolved in 1 ml TE buffer (10 mM Tris, 1 mM EDTA, pH 7.9). RNA precipitation was performed with 1.3 ml ice-cold EtOH per 500 µl and centrifuged at 10,000 × g for 15 min at 4 °C. Pellets were washed with 250 µl cold EtOH (70%, v/v) and centrifuged at 13,000 × g for 15 min. Pellets were dried at 37 °C and resolved in 500 µl TE buffer. 
SM and CEES treatment of cells
Ex vivo treatment of whole blood samples with SM and CEES
Blood from healthy volunteers was collected with an S-Monovette 10 ml 9NC (Sarstedt). Blood sample collection was approved by the Ethics Committee of the University of Konstanz. One-milliliter samples were prepared, directly treated with a 200 × pre-mix of CEES or SM, and subsequently incubated for 1 h at 37 °C. Afterwards, DNA was directly isolated from blood samples or stored at − 80 °C.
Isolation and treatment of PBMCs
Fresh blood (20-30 ml) was centrifuged at 300 × g for 10 min without brake. Plasma supernatant was discarded. The hematocrit proportion was diluted in pre-warmed PBS to 50 ml. A volume of 25 ml of the diluted samples were carefully applied to 15 ml Biocoll (Biochrome). After centrifugation at 900 × g for 15 min without brake, PBMCs were visible as a white 'cloud' above the Biocoll layer. PBMCs were collected on ice and diluted to 12.5 ml with PBS. After centrifugation at 300 × g for 10 min at 4 °C, the pellet was washed with cold PBS. Ten million cells were resuspended in 1 ml PBS and treated with CEES. Afterwards, cells were washed with pre-warmed PBS and centrifuged at 800 × g for 5 min. Then, pellets were stored at − 80 °C or PBMCs were seeded in RPMI medium (Thermo Scientific) with 10% fetal calf serum (Biochrome) and 1% penicillin-streptomycin (Thermo Scientific), and incubated at 37 °C in a humidified incubator with 5% CO 2 .
Dried blood spot analysis
A volume of 200 µl of ex vivo-treated blood was spotted on filter blotting paper (Hartenstein, 0.76 mm, 330 g/m 2 ) and dried over night at RT. Blood spots were dissolved in 1 ml PBS under agitation overnight at 37 °C. Samples were dried under vacuum and resolved in 200 µl PBS and DNA was isolated with the QIAamp DNA blood Mini Kit (Qiagen) according to the manufacturer's instructions and eluted with 100 µl TE buffer (10 mM Tris, 1 mM EDTA, pH 7.9).
DNA and RNA extraction
DNA from whole blood or PBMCs was isolated using the Blood & Cell Culture DNA Mini Kit (Qiagen) according to the manufacturer's instructions with an additional digestion step with 20 µg RNase (DNase and protease-free, Thermo Scientific) at 37 °C for 1 h, after resuspension of samples in buffer G2.
DNA and RNA from other cells were isolated using the AllPrep DNA/RNA Mini Kit (Qiagen) including the optional on-column DNase digestion with the RNase-free DNase Set (Qiagen). β-Mercaptoethanol was added to buffer RLT. Furthermore, an on-column RNase digestion was performed. After washing the AllPrep DNA spin column with buffer AW1, columns were washed with 350 µl buffer RW1 and centrifuged for 15 s at 8000 × g. RNase (20 µg) was mixed with 80 µl buffer RDD, applied to the column membrane, and incubated for 30 min at 30 °C. After washing with 350 µl buffer RW1, the purification procedure was continued with buffer AW2 according to the manufacturer's instructions.
RNA from whole blood was isolated using the RNeasy Mini Kit (Qiagen), including the optional on-column DNase digestion. To lyse the blood, 5 ml Red Blood Cell Lysis buffer (15.5 mM NH 4 Cl, 1 mM KHCO 3 , and 10 mM EDTA) was added to 1 ml blood and samples were incubated on ice for 10 min and vortexed thoroughly. After centrifugation at 400 × g for 10 min at 4 °C, the pellet was washed with 2 ml RBL buffer and centrifuged again. Cells were lysed with RLT buffer including β-mercaptoethanol and homogenized with a QIAshredder according to the manufacturer's instructions.
Cytoplasmatic RNA was isolated from cells using the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions for the isolation of cytoplasmatic RNA including the lysis of plasma membranes by buffer RLN. Nuclei were removed by centrifugation and used for isolation of nuclear RNA. miRNA was isolated using the HighPure miRNA Isolation Kit (Roche) according to the manufacturer's instructions.
To digest DNA or RNA, a 10 × master mix was prepared with 20 U benzonase nuclease (Sigma-Aldrich) and 40 µg DNase I (Roche) or 200 µg RNase, respectively, in Tris/ MgCl 2 (630 mM/63 mM, pH 8). The final concentrations of the buffer in samples were Tris/MgCl 2 (10.3 mM/1 mM). Samples were incubated for 2 h at 37 °C. Afterwards, a mastermix (10 × concentrated) with 50 U alkaline phosphatase from bovine intestine mucosa (Sigma-Aldrich) and 2.5 U phosphodiesterase I (Affymetrix) was prepared in NaOAc (final concentration 12.4 mM, pH 7.8), added to the samples, and incubated for 2 h at 37 °C. Ultrafiltration was performed with NanoSep Omega 10K centrifugal devices (Pall) for 10 min at full speed. Thermal hydrolysis of DNA adducts was achieved by incubation for 20 min at 90 °C. RNA was hydrolyzed for 1 h at 90 °C.
Annexin V/PI analysis
Five million cells were seeded in 6-well plates 1 day prior to treatment. Twenty-four hours after treatment, medium was collected, and cells were detached. Cells were centrifuged at 1,600 × g for 5 min. Four million cells/ml were resuspended in Annexin V binding buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) and 195 µl were stained with 5 µl Annexin V-FITC conjugate (Enzo Life Technologies) for 15 min in the dark. Afterwards, 200 µl PI staining solution [10 µg/ml PI (Sigma-Aldrich) in Annexin-binding buffer] was added and samples kept on ice until measurement with a FACSVerse instrument (BD Biosciences). Per condition, 20,000 cells were analyzed.
AlamarBlue assay
Three thousand cells per well were seeded in a 96-well plate in technical triplicates. At the next day, cells were washed with PBS and treated with CEES. After 1 h, cells were washed again with PBS and medium was added. After additional incubation for 24, 48, and 72 h, 10 µl AlamarBlue (10 × concentrated, Thermo Scientific) was added to each well and incubated for 3 h at 37 °C in the dark. To stop the reaction, 50 µl SDS (3% w/v) was added; plates were sealed and stored at 4 °C in the dark. Fluorescent signals were detected using a Varioskan Flash reader (Thermo Scientific) (Ex.: 570 nm/Em.: 585 nm).
Immuno slot blot assay
The protocol was adapted from . DNA was diluted to 50 µg/ml in 0.4% (v/v) formamide and 11.1% (v/v) formaldehyde in TAE buffer (20 mM Trizma base, 1.3 mM EDTA, pH 8). Denaturation was performed at 52 °C for 20 min. Afterwards, samples were stored at − 80 °C. Slots were washed once with PBS and with 6 × SCC buffer (20 × SCC buffer: 340 mM tri-sodium-citrate, 3 M NaCl), DNA was diluted to 1 µg in 200 µl PBS (1:10), samples were loaded with a negative pressure of 350 mbar on an Amersham Hybond-N+ membrane (GE Healthcare). Slots were washed with PBS and 2 × SCC buffer. Afterwards, the membrane was air dried for 15 min and DNA was fixed at 80 °C for 2 h. The membrane was washed twice with 0.2 × SCC buffer for 15 min and incubated with Dako Protein Block solution (Agilent) for 20 min. The antibody 2F8 (TNO, The Netherlands, 1:7000 in Dako Antibody Diluent, Agilent) was applied overnight at 4 °C. After washing thrice with Tris-buffered saline with Tween20 (TBS-T) for 5 min, the membrane was incubated with secondary antibody [goat anti-mouse HRP, Millipore, (1:2000) in milk] for 1 h at 37 °C, again washed thrice with TBS-T for 5 min, and chemiluminescence was detected via ECL reaction.
Synthesis and validation of analytical standards
The nucleosides 2′-deoxy-guanosine (dG) or 2′-deoxyadenosine (dA) (unlabeled from Sigma-Aldrich, 800 µg/ml or 13 C, 15 N-labeled from Euriso-Top, 1 mg/ml in Na 2 HPO 4 buffer) were treated with 5 mM CEES or 1 mM SM and incubated for 4 h at RT and stored at − 20 °C overnight. Thermal hydrolysis was achieved at 90 °C for 1 h and 5 mg treated dG or dA was pre-purified with a Discovery DSC-18 SPE tube (5 g per 20 ml, Sigma-Aldrich). Columns were equilibrated with 8 ml methanol (MeOH) and 8 ml 1% MeOH (v/v). After sample loading, columns were washed initially with 30 ml 1% MeOH (v/v) (20 ml for ETE-Ade) and then with 30 ml 5% MeOH (v/v) (8 ml for ETE-Ade). Elution was performed with 30 ml 10% MeOH (v/v) and 30 ml 15% MeOH (v/v), and 16 ml 20% MeOH (v/v) and 8 ml 80% MeOH (v/v). Two additional elution steps with 8 ml MeOH were performed for HETE-Ade. ETE-Ade was additionally washed with 8 ml 15% MeOH (v/v), 16 ml 20% MeOH (v/v), and 16 ml 20% MeOH (v/v) in 5% formic acid (v/v). ETE-Ade was eluted with 16 ml 30% MeOH (v/v) in 5% formic acid (v/v), 16 ml 40% MeOH (v/v) in 5% formic acid (v/v), 16 ml 50% MeOH (v/v) in 5% formic acid (v/v), and 8 ml 80% MeOH (v/v). Columns were regenerated with 8 ml MeOH and re-used five times.
Final purification was performed on a 2695 Alliance Separation Module (Waters) with a Nucleodur C 18 HTec column (3 µm, 2 × 125 mm, Machery-Nagel). ETE-Gua was purified with a gradient starting with 100% solvent A (ammonium acetate buffer, 2 mM) at a flow of 0.2 ml/min. Solvent B (acetonitrile with 0.1% acetic acid) was increased to 15% within 25 min, and then further increased to 30% and held constant for 5 min. ETE-Ade, HETE-Gua, Bis-Gua, and HETE-Ade were purified with a normal or SemiPrep Synergi Fusion-RP column (80 Å, 4 µm, 250 × 4.6 mm/250 × 10 mm, Phenomenex) with a flow of 0.7 or 3.3 ml/min. The gradient started with 100% A and increased within 5 min to 7.5% B. After a runtime of 40 min, 15% B was reached, further increased to 30% within the next 5 min, and held constant for another 5 min.
UV/Vis spectra of each adduct were acquired with an Ultrospec 2100 pro spectrophotometer (Amersham Biosciences). Molar extinction coefficients were ε 284 = 7400 l × mol −1 × cm −1 for mono-guanine adducts at pH 7 (Ludlum et al. 1994) , ε 270 = 17,400 l × mol −1 × cm −1 for mono-adenine adducts and ε 265 = 15,700 l × mol −1 × cm −1 for Bis-Gua at pH1 (Batal et al. 2013a ) were used to calculate concentrations. Product ion scans were performed at a high-end Xevo TQ-S triple quadrupole mass spectrometer (Waters).
Isotope dilution UPLC-MS/MS quantification
Analyses were performed on an ACQUITY UPLC H-class coupled to a Xevo TQ-S triple quadrupole MS (Waters). An ACQUITY UPLC BEH C18 column (50 × 2.1 mm I.D., 1.7 µm, 130 A, Waters) was used for the chromatographic separation of analytes. For the analysis of RNA, adducts were separated with a flow of 0.8 ml/min. Mobile phase A was Millipore water and B was acetonitrile (LC-MS grade, Carl Roth), both supplemented with 0.01% formic acid (Sigma-Aldrich). The initial conditions were 100% A. B was increased to 5% until a runtime of '2.5 min' and held constant until '4 min'. Then, B was further increased to 15% until '5 min', to 30% until '5.5 min', and then held constant until '6 min'. DNA adducts were separated with a flow of 0.35 ml/min. In an initial gradient, solvent B was increased to 15% until a runtime of '5 min', further increased to 30% until '6 min', and then held constant until '7 min'.
The source settings in positive ionization mode were set to: Capillary: 0.7 kV, Cone: 11 V, Source Offset: 50 V, Source Temperature: 150 °C, Desolvation Temperature: 500 °C, Cone Gas Flow: 150 l/h, Desolvation Gas Flow: 1000 l/h, Collision Gas Flow: 0.15 ml/min, and Nebuliser Gas Flow: 7 bar. The analyzer was set to high mass resolution.
The 
Method validation
The linear range of 1-1000 fmol of analytes was determined by serial dilution of standard stock solutions. The LOD and LOQ were determined at the lowest amount detectable at S/N ratios of 3 and 10, respectively. Samples of low-, medium-, and high-quality control concentrations (LQC, MQC, and HQC) were prepared with an amount of 5, 50, and 500 fmol of each adduct, respectively. According to the FDA guidelines (FDA 2005) , intraday and interday variations, which are measures for the precision of a method, were determined as n = 5 for all three concentration levels. Recovery and matrix effects were determined according to the guidelines of the European Medicines Agency (EMA 2011) by preparing three different sets of LQC, MQC, and HQC, each n = 3. In Set 1, standards were spiked into digested, hydrolyzed blank matrix. In Set 2, standards were spiked into water, and in Set 3, standards were spiked into non-hydrolyzed blank matrix and afterwards hydrolyzed. By dividing the peak areas of Set 3 and Set 1 recovery rates were calculated. The ratio of the peak areas of Set 1-to-Set 2 determined the respective matrix effect. All sets (1-3) were normalized to internal standards. Potential analyte losses due to short-term storage at RT and 37 °C were determined for 6, 12, and 24 h of storage. Potential analyte losses due to long-term storage were measured after 2 and 4 weeks of storage at − 20 °C and − 80 °C. In addition, up to three freeze-thaw cycles were measured. Samples were analyzed in triplicate for LQC, MQC, and HQC.
RESULTS
Method development and synthesis of internal standards
To develop chromatographic and mass spectrometric methods for the analysis of the major SM and CEES-induced adducts, isolated calf thymus DNA or yeast RNA was first used as model systems. For sample preparation, DNA or RNA was enzymatically hydrolyzed to nucleotides with benzonase as well as DNase I or RNase A, respectively. Afterwards, nucleosides were generated by incubation with alkaline phosphatase and phosphodiesterase I. For the analysis of a key set of SM and CEES-induced nucleic acid adducts (Fig. 1) , appropriate UPLC gradients were developed, resulting in baseline separation of most DNA or RNA adducts from canonical nucleosides with retention times of ~ 4-5 min for CEES-induced DNA adducts, 3-4 min for CEES-induced RNA adducts, and 2-3 min for SM-induced DNA and RNA adducts (Suppl. Figure 1) . In CEES-treated samples, four nucleoside-derived adducts were detected, i.e., N7-ETE-dG/N7-ETE-rG and N3-ETE-dA/N3-ETE-rA (N.B. rG and rA refer to ribonucleosides), as well as spontaneously hydrolyzed nucleobase adducts, i.e. N7-ETE-Gua and N3-ETE-Ade. In the case of SM-treated samples, N7-HETEdG/N7-HETE-rG, N3-HETE-dA/N3-HETE-rA, N7-HETEGua, Bis-Gua, and N3-HETE-Ade were detected (Fig. 1) . To further improve sensitivity, thermal hydrolysis was performed by incubating DNA samples at 90 °C for 20 min. Due to the higher stability of the N-glycosidic bond, RNA adducts were hydrolyzed at 90 °C for 60 min. It is important to note that SM-induced mono-adducts can be unambiguously discriminated from CEES-induced mono-adducts in the mass spectrometric analysis, because of the additional hydroxyl group at the HETE side chain, which is absent in the CEES-induced ETE side chain, leading to a difference in m/z ratios of 16.
To synthesize suitable internal chemical standards for the absolute quantitation of DNA lesions, 13 C, 15 N-labeled nucleosides were treated with SM and CEES. Pre-purification was achieved by C18 solid-phase extraction and final purification was performed via HPLC. The chemical standards were characterized by UV/Vis spectroscopy and UPLC-MS/MS fragmentation-induced product ion scans. The absorbance maxima of guanine adducts were at 285 nm, of adenine adducts at 264 nm, and of Bis-Gua crosslinks at 275 nm (Suppl. Figure 2) . Product ion scans of nucleoside adducts led to fragments of their corresponding nucleobase adducts, e.g., (H)ETE-Gua after the fragmentation of (H) ETE-dG, as well as the fragment of the respective alkylating agent, i.e., [HETE] + (m/z 105.0) or [ETE] + (m/z 89.0) (cf. Fig. 1 ). Nucleobase adducts led to [HETE] + or [ETE] + , whereas Bis-Gua led to the expected fragment of m/z 210.0 (Suppl. Figures 3 and 4 , cf. Fig. 1 ).
Calibration curves of unlabeled standards spiked with isotope-labeled standards showed a linear range of detection of at least two orders of magnitudes (Suppl. Figure 5) . The sensitivity was determined with a lower limit of detection (LLOD, S/N = 3) of 0.1-0.75 fmol and a lower limit of quantification (LOQ, S/N = 10) of 0.25-1 fmol, depending to the respective analyte (Table 1) . According to the EMA guidelines (EMA 2011), recovery and matrix effects were determined. All values were found to be within the acceptable limits suggested by EMA. Quality controls (QC) were prepared over a low (LQC), medium (MQC), and high (HQC) concentration range of 5, 50 and 500 fmol of each adduct, respectively. The values of percent relative standard deviation (%RSD), which is a measure for the precision of a method, were within the range of < 20% for LQCs and of < 15% for MQCs and HQCs for samples measured on the same day (intraday precision) and on different days (interday precision), except for Bis-Gua measurements, which showed %RSDs < 30% (Table 2) . These values are fully compatible with FDA guidelines for the validation of analytical procedures (FDA 2005) . Furthermore, three rounds Table 2 Analyses of recovery rates, matrix effects, and precision values
Recovery and matrix effects of standard substances spiked to blank HaCaT DNA were determined according to EMA guidelines (EMA 2011). Precision was determined according to FDA guidelines (FDA 2005) . Standard samples were prepared over a range of 5, 50 and 500 fmol, representing low (LQC), medium (MQC) and high (HQC) concentration quality controls, respectively a n = 4 instead of n = 5 of successive freeze-thaw cycles as well as short-term and long-term storage did not affect the stability of the tested analytes (Table 3) . The successful validation of the UPLC-MS/MS methods sets the basis for toxicological and mechanistic investigations of SM and CEES-induced nucleic acid damage in several different biological model systems, i.e., isolated DNA/ RNA and nucleic acids isolated from different cell culture models as well as from ex vivo-treated human whole blood samples and rat skin biopsies.
Analyses of SM and CEES-induced nucleobase adducts in isolated DNA and RNA
The matrices of lowest complexity used in this study were pure nucleic acids, such as isolated CT-DNA and yeast RNA. In these cases, CEES and SM directly reacted with the respective nucleic acid without potential interference of other influencing factors present in cellular systems. CT-DNA was treated with increasing concentrations of CEES or SM leading to the formation of the respective DNA adducts in a dose-dependent manner (Fig. 2 ). Adducts were detectable at concentrations ≥ 10 nM CEES (Fig. 2a) and > 100 nM SM (Fig. 2b) . Furthermore, several SM-induced DNA crosslinks were identified, such as previously reported Bis-Gua, but also two so far unreported adducts, i.e., crosslinks of guanine and adenine (Gua-ETE-Ade) and of two adenines (Bis-Ade) (Suppl. Figure 6A ). Treatment with 100 µM CEES resulted in molar percentages of 60% ETEGua and 40% ETE-Ade, whereas SM treatment resulted in the induction of 81.3% HETE-Gua and 18.7% HETE-Ade. Similarly, in yeast RNA, CEES and SM-induced adducts were detectable in a concentration-dependent manner with similar sensitivities as observed in DNA, i.e. ≥ 10 nM CEES and ≥ 100 nM SM (Fig. 3a, b) . Compared to DNA, the percentages of ETE-Gua and HETE-Gua were higher, i.e., 96% and 99%, respectively. To compare our MS-based method with a completely independent method for the detection of SM and CEES-induced DNA adducts, immunochemical detection with the 2F8 antibody against (H)ETE-Gua was performed . Statistically significant DNA adduct induction was visible after treatment with 500 µM CEES and 100 µM SM (Fig. 2c, d ). In RNA, treatment with ≥ 100 µM CEES and SM resulted in statistically significant adduct induction (Fig. 3c, d ). Our mass spectrometric approach is, therefore, 3-4 orders of magnitudes more sensitive than the immunochemical detection. Furthermore, the UPLC-MS/MS-based detection exhibits full chemical specificity without the limitation of potential antibody cross-reactivity.
In a next step, DNA adducts were examined in the keratinocyte cell line, HaCaT, and in the lung carcinoma cell line, A549, which as skin-and lung-derived cells represent the most relevant SM-target tissues. Cellular systems consist of a more complex matrix than isolated DNA, since the toxicant has to pass several membranes to reach nuclear DNA, thereby potentially leading to lower effective concentrations. Moreover, DNA and RNA must be isolated from cells, which potentially lead to some loss of the analytes. In both cellular systems, DNA adducts were detectable after treatment with ≥ 100 nM CEES (Fig. 4a, b) . In HaCaT cells, ETE-Gua and ETE-Ade adducts were induced at relative frequencies of 75.1% and 24.9%, respectively. In A549 cells, ETE-Gua and ETE-Ade adducts were induced at relative frequencies of 94.6% and 5.4%, respectively. After SM treatment, DNA adducts were detectable after treatment with ≥ 100 nM SM (Fig. 4c, d ). The molar percentage of HETEGua and HETE-Ade in HaCaT and A549 cells were about 89-90% and 10-11%, respectively. Interestingly, CEES induced about five-to-tenfold more mono-alkylated adducts than SM, suggesting different toxicokinetics and dynamics of the two substances. In addition, in both cell lines, RNA adducts were investigated (Fig. 5) . The detection limits corresponded to treatment concentrations of 100 nM CEES and SM, which was in the same range as for cellular DNA. In both cell lines, RNA adducts occurred at a distribution of 95% ETE-Gua and 5% ETE-Ade after CEES treatment, whereas SM induced an even higher percentage of HETEGua of 98.6%. In addition, nucleobase adducts were analyzed in different RNA pools, such as RNA extracted from the nucleus, i.e. mainly rRNA, the cytoplasm, including mRNA and tRNA, as well as in miRNA (Suppl. Figure 7) . Between the different RNA pools, no considerably differences were observed.
Time-course analyses of adduct stability in different cellular in vitro systems
To gain insights into the kinetics of adduct induction and repair, time-course analyses were performed in HaCaT and A549 cells. Appropriate doses were chosen according to toxicity testing via AlamarBlue and cell death staining. In both cell lines, 100 µM CEES did not significantly affect cell viability for up to 3 days (Suppl. Figure 8 ). In addition, AnnexinV/PI staining revealed no increased cytotoxicity after treatment with 100 µM CEES for 24 h up to 3 days (Suppl. Figure 9 ). Therefore, 100 µM CEES was considered as a suitable concentration for long-term treatment. For reasons of comparability, we also chose a concentration of 100 µM SM, although, at this dose, some cytotoxicity has been observed (Mangerich et al. 2016) , which needs to be considered, when interpreting the data. CEES treatment led to a rapid adduct induction already 5 min after treatment, whereas SM treatment led to a further increase in adduct levels up to 1 h after treatment (Fig. 6 ). Afterwards, a constant decrease in adduct levels was observed, but DNA adducts were still clearly detectable at least for 6 days after treatment, in particular in the case of SM-treated samples. The half-life (τ 1/2 ) values of HETE-Gua were determined to be 23.4 h and 69.5 h in HaCaT and A549 cells, respectively. τ 1/2 of Bis-Gua was 49.7 h in HaCaT cells and 34.1 h in A549 cells. τ 1/2 of HETE-Ade was 11.6 h in HaCaT, whereas 23.5 h in A549 cells. Although to a lower extent, CEES adducts were also still detectable 6 days after treatment, exhibiting τ 1/2 values in HaCaT and A549 cells of 21.7 h and 19.6 h for ETE-Gua, respectively, and 14.2 h or 7.1 h for ETE-Ade, respectively. Since cells were still Adducts were detected at concentrations ≥ 100 nM SM. n = 1. Immunochemically slot-blot detection of CEES (c) and SM (d) induced DNA adducts using the (H) ETE-Gua-specific antibody 2F8. Data are means ± SEM relative to control mean of three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a post hoc Bonferroni test. *p < 0.05, **p < 0.01, ***p < 0.001 proliferating (Suppl. Figure 10 ), the decrease of adducts might at least in part be due to dilution of unrepaired adducts by newly synthesized DNA. As compared to DNA adducts, similar results were obtained for RNA adducts. Thus, after CEES treatment adduct levels peaked already after 5 min (Fig. 7a, b) , whereas, after SM treatment, adduct levels increased until 1 h post-treatment (Fig. 7c, d) . In all cases, sustained adduct stability was evident, as signals were still clearly detectable 6 days after treatment, suggesting slow turnover of damaged RNA. For CEES-induced RNA adenine adducts, τ 1/2 values of ETE-Ade were 14.3 h and 12.1 h in HaCaT and A549, respectively. For presently unknown reasons, SM-induced RNA adenine adducts were not reliably detectable in both cell lines. ETE-Gua instead showed τ 1/2 values of 20 h and 18.8 h in HaCaT and A549 cells, respectively, whereas HETE-Gua showed τ 1/2 values of 66.3 h and 35.5 h in HaCaT and A549 cells, respectively. Both, for DNA as well as for RNA adducts, a rather slow decay of adducts was observed, indicating slow turn-over of adducts in both types of nucleic acids. Similar results were obtained in other cell lines, such as HepG2, HeLa, and Jurkat cells (data not shown), suggesting cell line independent mechanisms for the sustained adduct stability. Since immortalized cell lines might exhibit dysregulated DNA repair mechanisms, in a next step, we employed primary cells, which are considered fully repair proficient, for timecourse analyses.
Quantitative analyses of CEES-induced DNA adducts in primary cells and ex vivo-treated tissues
To investigate the stability of SM-and CEES-induced adducts in primary cells, human peripheral blood mononuclear cells (PBMCs) and normal human epidermal keratinocytes (NHEKs) were examined. Freshly isolated PBMCs were successfully cultivated ex vivo for up to 3 days. NHEKs were cultivated for at least 15 population doublings corresponding to about 25 days. Dose-dependent adduct induction was examined in both cell types. In NHEKs, adduct induction was similar as in cancer cell lines. In contrast, ETE-Gua-specific antibody 2F8. Data are means ± SEM relative to control mean of three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a post hoc Bonferroni test. *p < 0.05, **p < 0.01, ***p < 0.001 a seven-to-eightfold higher adduct induction was observed in PBMCs (Fig. 8) . Similar results were observed for RNA adducts in NHEKs (Suppl. Figure 11A) . As compared to cancer cell lines, both cell types were more sensitive against CEES, since already 100 µM CEES induced cytotoxic effects (Suppl. Figure 12 ). Therefore, we chose a sublethal dose of 10 µM CEES for time-course studies up to 3 days (Fig. 8b, d and Suppl. Figure 11B ). In both cell types, sustained adduct stability was detected, as especially in PBMCs about onehalf to one-third of the adducts were detectable 3 days postexposure. Since PBMCs are non-proliferative cells, in this case, a dilution effect due to DNA replication, as it is possible in cancer cell lines, can be excluded and adduct decay should occur exclusively due to DNA repair and potential cell loss. Therefore, these results suggest long adduct persistence, due to insufficient repair and/or delayed release of reactive molecules from subcellular reservoirs. To verify SM exposure in different relevant biological sample matrices, protocols for the purification of nucleic acid adducts from ex vivo-treated human whole blood samples (including dried blood spots) and rat skin samples were established. Adduct verification in ex vivo-treated human whole blood was achieved in DNA (Fig. 9) , as well as in RNA (Suppl. Figure 13) . As simultaneous isolation of DNA and RNA was not possible, a separate protocol for the isolation of RNA from blood was employed. The observed dose-response relationships were consistent with those observed in PBMCs (Fig. 9a) . Again, about 11-to 12-fold more adducts were induced by CEES treatment in blood cells compared to other cell types (Fig. 9b) . As blood components as well as cell types and numbers may vary between different human individuals or the time point of blood collection, the assay variability was tested by analyzing one donor at five different days (intradonor or interday variability, Fig. 9c ) and five different donors (interindividual variability, Fig. 9d ). Treatment with 10 µM CEES showed low variability in both data sets, which proved the robustness and suitability of the method for the analysis of blood samples.
Dried blood spots represent one of the easiest and most robust sampling procedures for subsequent biomarker analyses, since only low amounts of blood are necessary, and sampling can be conducted in remote and hard to reach geographical areas without the need of any special medical equipment. Furthermore, after drying, blood is assumed 
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to be non-infectious, which allows convenient shipping of the sample material without cooling and sophisticated biological safety measures. A recent study has demonstrated the suitability of this sampling procedure for the analysis of SM-protein adducts as biomarkers of exposure (John et al. 2016b ). Due to the high chemical stability of DNA at ambient temperatures, the dried blood spot method is expected to be equally well suited for the analysis of SM-DNA adducts.
To test if our mass spectrometric platform can be combined with the dried blood spot analysis, we performed proof-ofprinciple experiments using 200 µl ex vivo-treated blood samples spotted on a filter paper and dried overnight at room temperature. Afterwards, blood spots were resolved in PBS, and DNA was isolated via a commercially available DNA extraction kit. Of note, limits of detection were only tenfold higher compared to the analysis of fresh blood samples, as DNA adducts could be clearly detected after treatment with ≥ 1 µM CEES (Fig. 10a) . The higher detection limits can be explained by the different sample matrix and, therefore, altered DNA isolation efficiency, but also by the lower amount of blood used for the analysis. Since all blood-based analyses are restricted to the life span of DNAcontaining blood cells, we additionally tested skin samples. In this case, a longer detection window can be assumed compared to blood as well as higher adduct induction, due to direct contact with SM. For this reason, again, proofof-principle studies were performed with rat skin, treated ex vivo with CEES or SM and afterwards stored at − 20 °C. Tissue was homogenized and DNA was isolated. In rat skin treated with the lowest tested concentrations of CEES (i.e., 400 µM) or SM (i.e., 40 µM) DNA adducts were clearly detectable (Fig. 10b, c) . The higher detection limits may be due to dilution effects from unexposed surrounding tissue.
Discussion
In this study, we developed and applied a novel bioanalytical platform based on ID-UPLC-MS/MS for the quantitation of major SM-and CEES-induced nucleic acid adducts. These methods enable the absolute quantitation of DNA-as well as RNA adducts as mechanistically relevant biomarkers in a broad range of biological sample material, including blood samples and skin biopsies. Non-radioactive, isotope-labeled internal standards were synthesized from 13 C/ 15 N-labeled nucleosides. Dual-labeled standards at the site of the nucleobase are considered the most suitable standards, as the isotope incorporation is more E T E -G u a stable compared to deuterated standards. Deuterated standards are cheaper, as they are derived by exchange synthesis; however, for this reason, they are also prone to re-exchange with normal isotope atoms resulting in loss of the isotope label (Stokvis et al. 2005) . Furthermore, deuterated standards can lead to a shift in retention times as, sometimes, deuterated analytes elute before the non-labeled analyte and, therefore, potentially show different properties during the MS analysis (Iyer et al. 2004 ). In the current study, the standards of N7-(H)ETE-Gua and N3-(H)ETE-Ade were successfully synthesized and characterized by the signature of their UV/Vis spectra and mass spectrometric product ion scans. In addition, Bis-Gua standard has been successfully synthesized; however, for technical reasons, the obtained yield and quality has been too low for its use in absolute adduct quantitation. In our hands, enzymatic hydrolysis of DNA to nucleosides and subsequent thermal hydrolysis was the best choice for adduct analysis, because enzymatic digestion allowed very precise quantitation of canonical bases in a sample by concurrent UPLC-MS/MS measurements, which is necessary for normalization of the adduct levels, and thermal hydrolysis further increased the sensitivity of the method. Further validation of our MS platform demonstrated high linearity and sensitivity without any interfering matrix effects and high stability of the analytes in short-term and long-term storage experiments. Adducts in isolated CT-DNA were detected at treatment concentrations of ≥ 10 nM CEES and ≥ 100 nM SM. In cell culture models, adducts were detected at treatment concentrations ≥ 100 nM of CEES and SM, which is slightly higher than in isolated DNA and can be presumably attributed to the buffering capacity of cell membranes and other cellular components, such as GSH. With this, our newly developed UPLC-MS/MS methods display higher sensitivity and T im e a fte r tre a tm e n t specificity than immunohistochemically methods using the N7-HETE-Gua directed antibody 2F8 van der Schans et al. 1994) . In slot blot analyses using this antibody, statistically significant adduct induction in isolated DNA was revealed upon treatment with ≥ 100 µM SM and ≥ 500 µM CEES treatment, which corresponds to difference of a 3-4 order of magnitudes compared to the MS method. Furthermore, it is evident that the 2F8 antibody is not completely specific for N7-HETE-Gua adducts, as detection of adducts induced by CEES, SM, and nitrogen mustards, in DNA as well as in RNA was reported (Mangerich et al. 2016) . Moreover, it is not clear whether the antibody detects only mono-alkylated guanine or additionally Bis-Gua adducts or even adenine adducts, as it was produced in rabbits after injecting complete SM-treated CT-DNA. Based on radioactive-labeling techniques, SM-induced DNA adducts were reported previously at frequencies of ~ 61% N7-HETE-Gua, ~ 17% Bis-Gua, ~ 16% N3-HETEAde, and 0.1%, O 6 -HETE-Gua (Lawley and Brookes 1967; Ludlum et al. 1986 Ludlum et al. , 1994 . This implicated about three times more mono-alkylated guanine adducts compared to Bis-Gua and mono-alkylated adenine adducts, respectively. Recently, LC-MS/MS-based studies reported a higher percentage of mono-alkylated guanine (~ 81%) and lower proportions of Bis-Gua (~ 12%) and mono-alkylated adenine (~ 6%) in SMtreated isolated CT-DNA (Batal et al. 2013a) . Notably, in the same study, CEES induced almost exclusively monoalkylated guanine adducts (~ 98%). Somewhat contrary, in our study, mono-alkylated guanine adducts in CT-DNA constituted ~ 80% after SM treatment, but only ~ 60% after CEES treatment. Thus, SM induced four times more monoalkylated guanine adducts than mono-alkylated adenine adducts, while CEES induced only 1.5-fold more guanine adducts compared to adenine adducts. In comparison, Batal et al. found 13-fold more HETE-Gua than HETE-Ade, suggesting a higher percentage of adenine adducts in our study. SM treatment of isolated DNA led to the discovery of two DNA crosslinks, i.e., Gua-ETE-Ade and Bis-Ade, both of which were also detectable at low levels in cells and, to the best of our knowledge, have not been reported before. biological consequences and high mutagenic potential, as shown previously for O 6 -methyl-Gua (Thomas et al. 2015) . In cells, Batal et al. determined similar adduct levels as in isolated DNA after SM treatment, while CEES induced about 10% less mono-alkylated guanine adducts in cells than in CT-DNA (Batal et al. 2013a ). In our study, SM treatment induced ~ 90% mono-alkylated guanine adducts in HaCaT and A549 cells. On the other hand, CEES induced 75-95% guanine adducts in the different cell types. Wang et al. detected, in SM-treated HaCaT cells, a distribution of ~ 73% of mono-alkylated guanine, but only a minor proportion of mono-alkylated adenine of ~ 2% and a higher percentage of Bis-Gua of ~ 25% (Wang et al. 2015) . This is equivalent to 36.5 times more HETE-Gua than HETE-Ade adducts. Comparing all examined cell lines in the study by Wang et al., adduct levels varied considerably, i.e., 65-80% HETE-Gua, 20-30% Bis-Gua, and 1-2% HETE-Ade. Taken together, the comparison of the different studies demonstrates considerable variability in adduct distributions depending on the methods and experimental systems used. To this end, it is necessary to further validate the existing methods, ideally in side-by-side comparisons, to assess adducts levels in the future with the highest possible accuracy.
Time-course analyses of DNA and RNA adducts in several cellular systems treated with sublethal doses of SM and CEES revealed rapid adduct induction directly after treatment and long persistence up to several days. Interestingly, significant differences in induction kinetics were observed between CEES-and SM-treated samples. Thus, while peak adduct levels already occurred 5 min after CEES treatment, 
T im e a fte r tre a tm e n t C D Fig. 8 Analysis of DNA nucleobase adducts isolated from SM and CEES-treated primary cells. a Freshly isolated human PBMCs were treated with the indicated concentrations of CEES for 1 h. Adducts were detectable at concentrations ≥ 100 nM CEES. b PBMCs were treated with 10 µM CEES for 5 min and further incubated for the indicated periods. After 2 days, only a moderate decrease of adducts was detectable. c NHEKs were treated with the indicated concentrations of CEES for 1 h. Adducts were detectable at concentrations ≥ 1 µM CEES. d NHEKs were treated with 10 µM CEES for 5 min and further incubated for the indicated periods. After 3 days, a moderate decrease of adduct levels was detectable. Data in a represent means ± SEM of five independent experiments. Data in b-d represent means ± SEM of three independent experiments SM-induced adducts reached their maxima only 1 h after treatment. Such a delayed adduct formation in case of SM might be explained by different hydrolysis rates of CEES and SM, and/or by a delayed release of still active SM form subcellular compartments, potentially due to its altered physico-chemical properties compared to CEES. Of note, the delayed adduct formation in case of SM might represent a time frame, where SM scavengers could be applied as a means for therapeutic intervention (Steinritz and Thiermann 2016) . Our results were highly consistent with other MSbased methods, which revealed that SM-induced adducts are detectable for at least 14 days (Yue et al. 2015) or 21 days (Batal et al. 2014 ) in internal organs, or even 29 days in urine (Zhang et al. 2014 (Wang et al. 2015) , which are in Analysis of SM and CEES-induced DNA nucleobase adducts isolated from different biological matrices relevant for forensic purposes. a Dried blood spots of ex vivo CEES-treated blood samples were prepared and subsequently subjected to DNA isolation. Adduct induction was detectable at concentrations ≥ 1 µM CEES. Analysis of adduct levels in CEES-(b) or SM-(c) ex vivo-treated rat skin. DNA adducts were detected at concentrations ≥ 400 µM CEES and ≥ 40 µM SM. a n = 3, b, c. n = 1 the same range as values from our study. Of note, here, we demonstrate that SM-induced RNA adducts may also serve as candidate biomarkers of SM exposure. Thus, high RNA adduct levels were observed in isolated RNA, as well as cellular RNA, and adducts were at least as stable as DNA adducts over the examined periods of several days. As DNA repair might be altered in immortalized cell lines, we also monitored adduct levels over time in several primary cell systems. PBMCs were very sensitive against CEES, as they showed high induction of cell death as well as high adduct levels compared to cell lines and NHEKs. Here, again, adduct levels decayed slowly, suggesting slow turnover and/or inefficient repair of such adducts. Indeed, various repair-resistant DNA adducts have been reported in the literature, e.g., several bulky adducts were shown to be poor substrates for DNA repair (Geacintov and Broyde 2017) . Furthermore, some populations of PBMCs exhibit impaired DNA repair, e.g., monocytes are impaired in base excision repair (BER) and double strand break repair (DSB) repair (Bauer et al. 2011) . Experiments with repair-deficient cells showed that BER-deficient cells are only sensitive to the mono-alkylating CEES, whereas nucleotide excision repair (NER)-deficient cells are sensitive to both, CEES and SM, and in contrast, non-homologous end-joining (NHEJ) and homologous recombination (HR)-deficient cells are only sensitive to crosslinking SM (Jowsey et al. 2012 ). In addition to inefficient repair of DNA adducts, it is conceivable that subcellular lipid compartments form a reservoir for SM, which could lead to a long-lasting constant release of the reactive substance. This hypothesis is supported by the recent studies reporting the accumulation of intact SM or SM-induced DNA adducts in lipid-rich tissues (Xu et al. 2017; Yue et al. 2015) . Furthermore, prolonged half-lives of SM-induced DNA adducts were seen in lipid-rich cells (Wang et al. 2015) .
As it was a major aim of this study to develop an analytical platform to use SM-induced nucleic acid adducts as biomarkers in exposure verification, we performed adduct quantification in three different sample matrices that can be used for forensic purposes: first, human whole blood, as the standard sample type for biomarker analysis; second, dried blood spot of ex vivo-exposed whole blood, as dried blood spots allow easy handling of samples with regards to shipment and storage; third, (rat) skin samples, since skin biopsies can be used in sampling of potentially SM-exposed individuals, due to higher concentrations of analytes than in blood (although this sampling method is more invasive than blood collection). In all three cases, adduct detection was achieved with highly satisfactory sensitivities, which will allow SM exposure verification in authentic sample material. Thus, SM doses of Iranian victims were exposed to, corresponded to experimental treatment doses of ex vivotreated blood of 0.4-1.8 µM SM (Noort et al. 1999) . In our study, we could detect nucleobase adducts in human whole blood at treatment concentration of 0.1 µM SM. In the dried blood spot analysis, adducts could be clearly detected at treatment concentrations ≥ 1 µM CEES. Based on our data from in vitro test systems, showing that CEES and SM exposure was detected at similar treatment concentrations, it is expected that this sensitivity level also holds true for SM. In rat skin, the lowest tested dose was 40 µM SM. As concentrations of reactive SM are considered much lower in the blood stream compared to the skin, which is in direct contact with the agent, the higher detection limit in the skin samples will still be suitable for the verification of SM exposure in authentic sample material. Thus, all three matrices proved to be suitable to verify SM exposure.
In conclusion, in the present study, we have developed, validated, and applied a robust and versatile bioanalytical platform for the quantitation of CEES and SM-induced nucleic acid damage in relevant biological sample matrices. The UPLC-MS/MS platform is currently implemented into the method portfolio of the Institute of Pharmacology and Toxicology of the Bundeswehr, which is a laboratory designated by the OPCW for biomedical verification. This has already led to the first applications in follow-up research projects (Tsoutsoulopoulos et al., manuscript in preparation). Furthermore, in the future, this will enable exposure verification and pathological risk assessment of authentic samples from potentially SM-exposed victims by 2-3 completely independent sets of biomarkers, i.e., SM-protein adducts as well as SM-DNA/RNA adducts.
